{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:18:11Z","timestamp":1777569491073,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ajog.2019.12.273","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T12:00:07Z","timestamp":1579608007000},"page":"103.e1-103.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy"],"prefix":"10.1016","volume":"223","author":[{"given":"Rachel S.","family":"Mandelbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia A.","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Khoshchehreh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heena","family":"Purswani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise B.","family":"Morocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina E.","family":"Dancz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begum","family":"Ozel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.12.273_bib1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","article-title":"Management of endometrial precancers","volume":"120","author":"Trimble","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2019.12.273_bib3","first-page":"107","article-title":"New classification system of endometrial hyperplasia WHO 2014 and its clinical implications","volume":"16","author":"Sobczuk","year":"2017","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.ajog.2019.12.273_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2019.12.273_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2015.07.108","article-title":"Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia","volume":"139","author":"Matsuo","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-8258(02)00008-2","article-title":"Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer","volume":"88","author":"Wang","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib7","doi-asserted-by":"crossref","unstructured":"Shoupe D, Mishell DR Jr. The handbook of contraception: A guide for practical management. 2nd ed. 2016. In the series: Current clinical practice. Skolink NS, series editor. Totowa, NJ: Humana Press Inc.; 2016.","DOI":"10.1007\/978-3-319-20185-6"},{"key":"10.1016\/j.ajog.2019.12.273_bib8","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2019.12.273_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.maturitas.2006.12.004","article-title":"Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up","volume":"57","author":"Wildemeersch","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2019.12.273_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00404-019-05059-2","article-title":"Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia","volume":"299","author":"Ciccone","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.12.273_bib13","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2019.12.273_bib14","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/jnci\/djq393","article-title":"Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data","volume":"102","author":"Hadley","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2019.12.273_bib15","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.3854","article-title":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","volume":"29","author":"Austin","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2019.12.273_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gore.2018.09.001","article-title":"Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients","author":"Graul","year":"2018","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ajog.2019.12.273_bib17","article-title":"Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients","volume":"29","author":"Yang","year":"2018","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2019.12.273_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.12.273_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008034","article-title":"Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2019.12.273_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib22","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.12.273_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2011.06.025","article-title":"Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia","volume":"159","author":"Haoula","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2019.12.273_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/IGC.0000000000000669","article-title":"Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: a Korean Gynecologic-Oncology Group Study","volume":"26","author":"Kim","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.12.273_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2008.06.014","article-title":"Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only","volume":"111","author":"\u00d8rbo","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2003.07.002","article-title":"Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone","volume":"91","author":"Vereide","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib28","first-page":"122","article-title":"The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study","volume":"40","author":"Dolapcioglu","year":"2013","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/jwh.2016.5774","article-title":"Oral progestogens versus levonorgestrel-releasing intrauterine system for treatment of endometrial intraepithelial neoplasia","volume":"26","author":"Marnach","year":"2017","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2019.12.273_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/AOG.0b013e31828d6186","article-title":"Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma","volume":"121","author":"Hubbs","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2019.12.273_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2019.12.273_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2016.07.129","article-title":"Pharmacokinetics of the levonorgestrel-only emergency contraceptive regimen among normal-weight, obese and extremely obese users: a pilot study","volume":"94","author":"Matavio","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2019.12.273_bib35","first-page":"1839","article-title":"Using progestins in clinical practice","volume":"62","author":"Apgar","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajog.2019.12.273_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2015.12.010","article-title":"Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer","volume":"140","author":"Cholakian","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib37","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta19880","article-title":"A\u00a0randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial","volume":"19","author":"Gupta","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ajog.2019.12.273_bib38","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2019.12.273_bib39","first-page":"CD009458","article-title":"Oral and intrauterine progestogens for atypical endometrial hyperplasia","volume":"12","author":"Luo","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2019.12.273_bib40","unstructured":"Overweight and obesity. Global Health Observatory (GHO) data. World Health Organization. Available at: https:\/\/www.who.int\/gho\/ncd\/risk_factors\/overweight\/en\/. Accessed June 15, 2019."},{"key":"10.1016\/j.ajog.2019.12.273_bib41","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ygyno.2011.12.016","article-title":"Prospective phase II trial of the Levonorgestrel Intrauterine System (Mirena) to treat complex atypical hyperplasia and grade 1 endometrioid endometrial cancer","volume":"125","author":"Westin","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.12.273_bib42","doi-asserted-by":"crossref","first-page":"36 e1","DOI":"10.1016\/j.ajog.2012.05.012","article-title":"Biomarkers of progestin therapy resistance and endometrial hyperplasia progression","volume":"207","author":"Upson","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.12.273_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2016.10.015","article-title":"Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response","volume":"143","author":"Tierney","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820300284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820300284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:06:14Z","timestamp":1777403174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820300284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0002937820300284"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.12.273","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.12.273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}